Picture of Fagron NV logo

FAGR Fagron NV News Story

0.000.00%
be flag iconLast trade - 00:00
HealthcareConservativeMid CapHigh Flyer

Brief: Fagron FY Rebitda Up 13.9% Vs Year Ago

Feb 15 (Reuters) - Fagron NV  FAGRO.BR :
    * FAGRON DELIVERS STRONG PERFORMANCE WITH 12% TOPLINE GROWTH
AND
14% INCREASE IN REBITDA FOR FY 2023
    * 13.9% REBITDA INCREASE TRANSLATES TO 40BPS REBITDA MARGIN
UPLIFT
YOY
    * 2023 11.6% REPORTED REVENUE GROWTH (12.5% AT CER) AND
10.5%
ORGANIC REVENUE GROWTH AT CER SUPPORTED BY GROWTH ACROSS ALL
REGIONS
    * FY OPERATING CASH FLOW INCREASES BY 13.9% TO EUR 124.6
MILLION
RESULTING IN IMPROVED LEVERAGE RATIO OF 1.4X
    * FY 13.9% REBITDA INCREASE TRANSLATES TO 40BPS REBITDA
MARGIN
UPLIFT YOY TO 19.5%
    * FY '24 OUTLOOK OF HIGH SINGLE-DIGIT ORGANIC SALES GROWTH
AND
CONTINUED IMPROVEMENT IN PROFITABILITY
    * FY OPERATING CASH FLOW INCREASES BY 13.9% TO €124.6
MILLION
RESULTING IN IMPROVED LEVERAGE RATIO OF 1.4X
    * DIVIDEND PROPOSAL OF €0.30 PER SHARE (+20%)
    * OUTLOOK: ’24 HIGH SINGLE-DIGIT ORGANIC SALES GROWTH AND
CONTINUED IMPROVEMENT IN PROFITABILITY
    * FOR FULL YEAR 2024, WE EXPECT HIGH SINGLE-DIGIT ORGANIC
REVENUE
GROWTH AND OUR PROFITABILITY TO IMPROVE YOY
    * OUTLOOK: REMAIN CONFIDENT IN ACHIEVING OUR MID-TERM
OBJECTIVES
AND CONTINUE TO LOOK FOR ATTRACTIVE GROWTH OPPORTUNITIES THAT
SUPPORT OUR STRATEGIC AMBITIONS

Source text for Eikon:  urn:newsml:reuters.com:*:nGNE8fSFyx
Further company coverage:  FAGRO.BR 

 (Gdansk Newsroom)
 ((gdansknewsroom@thomsonreuters.com; + 48 58 7785110;))

Recent news on Fagron NV

See all news